UPDATE: JPMorgan Downgrades G1 Therapeutics (GTHX) to Neutral
Tweet Send to a Friend
(Updated - September 30, 2021 5:03 AM EDT)
JPMorgan analyst Anupam Rama downgraded G1 Therapeutics (NASDAQ: GTHX) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama downgraded G1 Therapeutics (NASDAQ: GTHX) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
